Hologic and LabCorp became the third and fourth commercial test makers to receive EUA designation for assays to detect the coronavirus that causes COVID-19.
Firms like LabCorp, Quest, and BioReference have launched tests but a lack of clarity around demand presents challenges for assessing what capacity is needed.
The Department of Health and Human Services selected the diagnostic test for development support through a streamlined process called an easy broad agency announcement.
Hologic said laboratories may leverage the random-access and open-access capabilities of its Panther Fusion system to broaden screening for the novel coronavirus.
On Monday Qiagen reiterated its preliminary 2019 earnings figures and addressed an investor's wrath, while Guardant Health highlighted its cancer testing plans.
